Allarity Therapeutics (ALLR) Earnings Date & Reports

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALLR is expected to report earnings to rise 19.05% to -25 cents per share on November 12

Allarity Therapeutics ALLR Stock Earnings Reports

Q3'26

Est.

$-0.25

Q2'26

Beat

by $0.04

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.02

The last earnings report on August 14 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 10.34K shares outstanding, the current market capitalization sits at 15.41M.

View a ticker or compare two or three

ALLR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ALLR